logo
Plus   Neg
Share
Email
Comment

Banco Santander To Report EUR 600 Mln Impairment; Backs Earnings, Dividend Goals

Banco Santander S.A. (BNC.L,BSBR,SAN), a Spanish retail and commercial bank, Wednesday announced that his Board has agreed to allocate 600 million euros as a goodwill impairment. The company further maintained its goal to increase dividend per share in 2017 and 2018; and earnings per share in 2017 and 2018, the latter by double digits.

The impairment includes 500 million euros as a result of the review of the Group's investment in Santander Consumer USA Holdings Inc or SCUSA. The impairment for SCUSA is driven by a reduction in the company's earnings relative to prior years. The impairment will be recognised in the fourth quarter.

At a Board meeting today in Brazil, the Board approved changes to its composition, as well as adjustments to the goodwill.

Further, the Board has agreed to appoint Ramiro Mato as Independent Director. He will also join the Board´s executive committee, as well as the Audit and the Risk Supervision, Regulation and Compliance Committees.

Matías Rodríguez Inciarte and Isabel Tocino will leave the board of directors to take on new roles.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Amid a government shutdown, the Senate voted Monday to move forward on a short-term spending bill to re-open the government. The Senate voted 81 to 18 in favor of limiting debate on the bill, which would fund the government through February 8th. Opera, a web browser for Windows, macOS, and Linux operating systems, has added cryptocurrency mining protection to its mobile browsers. It is part of the browser's ad blocker function. In its desktop-based versions, Opera had introduced cryptocurrency miner protection in early January. French drug giant Sanofi SA Monday announced an agreement to buy US-based hemophilia drugmaker Bioverativ Inc. (BIVV) for around $11.6 billion. The deal expands Sanofi's presence in specialty care and strengthens leadership in rare diseases. Sanofi shares were losing around 4 percent in the early morning trading in Paris.
comments powered by Disqus
Follow RTT